Sponsor or institution

Clinical trials and research at Jemincare

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• JYB1904 Injection for Chronic Spontaneous Urticaria in Adults

  This trial tests whether JYB1904 injections help adults with chronic spontaneous hives that aren’t well controlled by standard antihistamines.

  Recruiting Phase 3 Jemincare · Beijing · NCT07402213

• JMKX005425 for people with MSI‑H or dMMR advanced solid tumors

  This trial will try JMKX005425 in people with MSI‑H or dMMR advanced solid tumors to see if it is safe, well tolerated, how the body processes it, and whether it shows early signs of benefit.

  Recruiting Phase 1 Jemincare · Beijing · NCT07208136

• JMKX001899 combined with IN10018 and/or chemotherapy for advanced KRAS G12C non-small cell lung cancer

  This trial will test whether the experimental drug JMKX001899, given alone or with IN10018 and/or chemotherapy, is safe and shows signs of benefit for people with advanced non-small cell lung cancer that has the KRAS G12C mutation.

  Recruiting Phase 1 Jemincare · Guangzhou, Guangdong · NCT06946927

• JMKX003142 for rapidly progressive ADPKD

  This Phase 2 trial will test whether the oral medicine JMKX003142 is safe, well tolerated, and can slow disease progression in adults aged 18–55 with rapidly progressive ADPKD.

  Recruiting Phase 2 Jemincare · Beijing, Beijing Municipality · NCT06800651

• Treatment of malignant pleural effusion with JMKX000197 injection

  This study is testing a new injection called JMKX000197 to see if it can help people with malignant pleural effusion feel better when combined with a drainage procedure.

  Recruiting Phase 1 Jemincare · Beijing · NCT06740019

• Evaluating JYB1904 for Chronic Spontaneous Urticaria

  This study is testing a new injection called JYB1904 to see if it can help adults with chronic hives and itching who haven't found relief with regular allergy medications.

  Recruiting Phase 2 Jemincare · Beijing, Beijing Municipality · NCT06509334

• Evaluating JMKX003948 Tablets for Patients with Renal Cell Carcinoma

  This study is testing a new tablet called JMKX003948 to see if it is safe and effective for people with advanced kidney cancer.

  Recruiting Phase 1 Jemincare · Beijing · NCT06321250

Quick answers

How many clinical trials run by Jemincare are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 4, Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →